110 likes | 225 Views
Neuromodulation Market - Global Opportunity Analysis and Industry Forecast, 2014 - 2022", projects that the world neuromodulation market is expected to reach $11,717 million by 2022, registering a CAGR of 13.1% from 2016 to 2022. External neuromodulators are projected to grow with the fastest CAGR of 14.7%, as they are used externally by the body and hence the risks of implantation can be reduced. Transcutaneous Electrical Nerve Stimulation (TENS) devices occupy over three-fourths share of external neuromodulation devices. <br><br>View more about report at: https://www.alliedmarketresearch.com/neurostimulation-devices-market
E N D
Neuromodulation Market Global Opportunity Analysis and Industry Forecast, 2014 - 2022 Page No: 127 Publish: 2016
NEUROMODULATION MARKET OVERVIEW • Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons. This is in contrast to classical synaptic transmission, in which one presynaptic neuron directly influences a single postsynaptic partner. • Amongst the internal neuromodulation devices, spinal cord stimulation (SCS) is highest generator in the global market, owing to the growing number of product approvals and positive clinical outcomes. • A new report published by Allied Market Research, titled, "Neuromodulation Market - Global Opportunity Analysis and Industry Forecast, 2014 - 2022", projects that the world neuromodulation market is expected to reach $11,717 million by 2022, registering a CAGR of 13.1% from 2016 to 2022.
NEUROMODULATION MARKET KEY FINDINGS • Spinal cord stimulation (SCS) segment generated the highest revenue in 2015, and is projected to grow at a CAGR of 12.1% during the forecast period. • Metallic biomaterial is the major component of neurostimulators. • Repetitive Transcranial Magnetic Stimulation (RTMS) segment is expected grow at a CAGR of 16.0%. • By country, the U.S. led the global neuromodulation market. • Germany accounted for about one-third share of the European neuromodulation market in 2015.
KEY BENEFITS OF THE REPORT • The study provides an in-depth analysis of the world neuromodulation market with current trends and future estimations to elucidate the imminent investment pockets. • The report provides a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities. • The report provides actual historical figures for 2014 and 2015 and provides Y-o-Y forecasts for 2016 to 2022, considering 2015 as base year. • SWOT analysis studies the internal environment of the leading companies for strategy formulation.
KEY PLAYERS IN INDUSTRY • Medtronic plc • St. Jude Medical Inc • LivaNovaPLC • Boston Scientific Corporation • AlevaNeurotherapeuticsSA • BioControlMedical • BionessInc • EnteroMedicsInc • Nevro Corporation and NeuroPaceInc
NEUROMODULATION MARKET BY REGION • North America, Europe, Asia-Pacific, LAMEA
Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/neurostimulation-devices-market Follow Us On